PETS Files Routine 8-K for 'Other Event' on Jan 5, 2024

Ticker: PETS · Form: 8-K · Filed: 2024-01-08T00:00:00.000Z

Sentiment: neutral

Topics: regulatory-filing, other-events, routine-disclosure

TL;DR

**PETS filed a routine 8-K, no major news.**

AI Summary

PetMed Express, Inc. (PETS) filed an 8-K on January 8, 2024, reporting an 'Other Event' that occurred on January 5, 2024. This filing is a routine disclosure, indicating no major financial or operational changes, but rather a standard update to their public record. For investors, this means there's no immediate new information impacting the company's valuation or future prospects, suggesting business as usual.

Why It Matters

This filing is a standard procedural update, indicating no significant new developments that would immediately affect PetMed Express's stock price or business operations. It's a 'no news is good news' scenario for current or prospective shareholders.

Risk Assessment

Risk Level: low — The filing is for 'Other Events' and contains no specific details indicating any material risks or opportunities.

Analyst Insight

A smart investor would view this filing as a non-event, confirming no immediate material changes for PetMed Express, Inc. and would continue to monitor for more substantive disclosures like earnings reports or strategic announcements.

Key Numbers

January 5, 2024 — Date of earliest event reported (Indicates when the 'Other Event' occurred.)
January 8, 2024 — Date of report filing (Indicates when the 8-K was officially submitted to the SEC.)
000-28827 — Commission File Number (Unique identifier for PetMed Express, Inc. with the SEC.)
$.001 — Par value per share (The nominal value of each share of Common Stock.)

Key Players & Entities

PetMed Express, Inc. (company) — the registrant filing the 8-K
PETS (company) — the trading symbol for PetMed Express, Inc.
NASDAQ Global Select Market (company) — the exchange where PETS Common Stock is registered
January 5, 2024 (date) — the date of the earliest event reported
January 8, 2024 (date) — the date the 8-K report was filed
000-28827 (dollar_amount) — Commission File Number
65-0680967 (dollar_amount) — I.R.S. Employer Identification No.
420 South Congress Avenue, Delray Beach, Florida 33445 (company) — Address of principal executive offices
561-526-4444 (dollar_amount) — Registrant’s telephone number
$.001 (dollar_amount) — par value per share of Common Stock

Forward-Looking Statements

PETS stock price will remain stable in the short term due to the lack of material news. (PETS) — high confidence, target: 2024-01-31
No significant operational changes are expected for PetMed Express, Inc. based on this filing. (PetMed Express, Inc.) — high confidence, target: 2024-03-31

FAQ

What was the specific 'Other Event' reported by PetMed Express, Inc. on January 5, 2024?

The filing does not specify the exact nature of the 'Other Event.' It only states that an event categorized as 'Other Events' occurred on January 5, 2024, and was reported via this 8-K filing on January 8, 2024.

What is the trading symbol and the exchange where PetMed Express, Inc.'s common stock is registered?

PetMed Express, Inc.'s common stock trades under the symbol PETS and is registered on the NASDAQ Global Select Market.

What is the par value of PetMed Express, Inc.'s Common Stock?

The par value of PetMed Express, Inc.'s Common Stock is $.001 per share.

Is PetMed Express, Inc. considered an 'emerging growth company' according to this filing?

No, the filing indicates with an 'o' (unchecked box) that PetMed Express, Inc. is not an emerging growth company as defined by Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

What is the business address and phone number of PetMed Express, Inc. as stated in the filing?

The business address is 420 South Congress Avenue, Delray Beach, Florida 33445, and the business phone number is (561) 526-4444.

From the Filing

0001040130-24-000002.txt : 20240108 0001040130-24-000002.hdr.sgml : 20240108 20240108160407 ACCESSION NUMBER: 0001040130-24-000002 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20240105 ITEM INFORMATION: Other Events FILED AS OF DATE: 20240108 DATE AS OF CHANGE: 20240108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PETMED EXPRESS INC CENTRAL INDEX KEY: 0001040130 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 650680967 STATE OF INCORPORATION: FL FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-28827 FILM NUMBER: 24520039 BUSINESS ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 BUSINESS PHONE: (561) 426-4444 MAIL ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 8-K 1 pets-20240105.htm 8-K pets-20240105 0001040130 FALSE 0001040130 2024-01-05 2024-01-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM  8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported):  January 5, 2024 PetMed Express, Inc. (Exact name of registrant as specified in its charter) Florida 000-28827 65-0680967 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 420 South Congress Avenue , Delray Beach , Florida 33445 (Address of principal executive offices) (Zip Code) ( 561 )  526-4444 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $.001 per share PETS NASDAQ Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 8.01 Other Events. As part of the PetMeds Express, Inc. Board of Directors’ (“Board”) ongoing Board composition and succession planning, the Board has appointed Leslie C. G. Campbell as Chairman of the Board effective January 5, 2024. Ms. Campbell succeeds Dr. Gian Fulgoni who will remain on the Board and will also continue to chair the Board’s Corporate Governance and Nominating Committee. Ms. Campbell has served on the Board since 2018, currently serves as Chair of the Compensation Committee and a member of the Audit Committee and Corporate Governance and Nominating Committee, and previously served as Chairman of the Corporate Governance and Nominating Committee. 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: January 8, 2024 PET